Companies · USAspending parent record
GLAXOSMITHKLINE, LLC
No confirmed stock ticker. 1 recipient record grouped under this USAspending parent (UEI FRHTPHMZMX47).
obligated to date on 1 non-competed award of $1M+ signed FY2024–26
Obligated to date, not spending in a year. Selected awards only (rule r5-v1): not this company's not-competed share.
obligated to date: 75A50325C00019, Department of Health and Human Services, signed FY2025
No confirmed stock ticker, so no member trades are matched to this company.
Federal contract awards in our records
Each row is one prime contract award on USAspending.gov; “USAspending” opens its official page.
What this table covers: every award signed in FY2024–26 that the agency coded “not competed” and that is $1 million or more, plus any award of $10 million or more (rule r5-v1). Smaller competed awards are not in it, so it is not this company’s total federal business and it cannot show a not-competed share. “Obligated to date” is the total committed on the award so far, including later modifications (USAspending, as of Oct 3, 2026), not the amount at any earlier date.
| Signed in | Non-competed awards | Obligated to date | Other awards $10M+ | Obligated to date |
|---|---|---|---|---|
| FY2024 | None in this set | — | 4 | $59.2M |
| FY2025 | 1 | $45.5M | None in this set | — |
| FY2026incomplete | None in this set | — | None in this set | — |
FY2026 is incomplete: the Department of Defense reports contract actions 90 days late, and older awards keep growing through modifications, so these amounts will rise. Source: USAspending.gov, as of Oct 3, 2026.
| Source | |||||
|---|---|---|---|---|---|
| 75A50325C00019RELENZA (ZANAMIVIR) ROTADISK, 5MG | Department of Health and Human Services | Sep 26, 2025FY2025 | Not competedOnly one source-other (FAR 6.302-1 other) | $45,499,950 | USAspending |
| 75A50124F61014Order under IDV 75A50122D00002THIS TASK ORDER ESTABLISHES SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION OF MEDICAL COUNTERMEASURES (MCMS) FOR PANDEMIC INFLUENZA AND EMERGING DISEASES PREPAREDNESS AND RESPONSE UNDER CONTRACT 75A50122D00002. | Department of Health and Human Services | May 10, 2024FY2024 | Full and open competition | $18,193,095 | USAspending |
| 75A50124F61013Order under IDV 75A50122D00002THE PURPOSE OF THIS TASK ORDER IS TO ESTABLISH FILL/FINISH ACTIVITIES FOR ADJUVANT (AS03) TO SUPPORT THE COVID-19 FEDERAL RESPONSE- MULTI-DOSE VIALS FOR HHS UNDER IDIQ CONTRACT #75A50122D00002. | Department of Health and Human Services | Feb 27, 2024FY2024 | Full and open competition | $15,411,200 | USAspending |
| 75A50124F61012Order under IDV 75A50122D00002THE PURPOSE OF THIS HHS TASK ORDER IS TO PROCURE SERVICES FOR THE STORAGE AND STABILITY OF BULK LOTS & FINAL CONTAINERS OF-ADJUVANT( AS03) COVID-19 FUNDS. | Department of Health and Human Services | Feb 20, 2024FY2024 | Full and open competition | $14,047,404 | USAspending |
| 75A50124F61015Order under IDV 75A50122D00002THIS TASK ORDER ESTABLISHES SERVICES FOR STORAGE AND STABILITY OF AS03 ADJUVANT MANUFACTURED TO SUPPORT THE COVID-19 FEDERAL RESPONSE IN BULK LOTS AND FINAL CONTAINERS FOR THE LIFE OF THE MATERIAL. ALL OPTION PERIODS ARE HEREBY EXERCISED UNDER THIS | Department of Health and Human Services | Jun 17, 2024FY2024 | Full and open competition | $11,538,800 | USAspending |
FY2024–26 awards to GLAXOSMITHKLINE, LLC, largest first (obligated to date)
- 75A50325C00019RELENZA (ZANAMIVIR) ROTADISK, 5MG
- Signed
- Sep 26, 2025FY2025
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $45,499,950
- 75A50124F61014Order under IDV 75A50122D00002THIS TASK ORDER ESTABLISHES SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION OF MEDICAL COUNTERMEASURES (MCMS) FOR PANDEMIC INFLUENZA AND EMERGING DISEASES PREPAREDNESS AND RESPONSE UNDER CONTRACT 75A50122D00002.
- Signed
- May 10, 2024FY2024
- Competition
- Full and open competition
- Obligated to date
- $18,193,095
- 75A50124F61013Order under IDV 75A50122D00002THE PURPOSE OF THIS TASK ORDER IS TO ESTABLISH FILL/FINISH ACTIVITIES FOR ADJUVANT (AS03) TO SUPPORT THE COVID-19 FEDERAL RESPONSE- MULTI-DOSE VIALS FOR HHS UNDER IDIQ CONTRACT #75A50122D00002.
- Signed
- Feb 27, 2024FY2024
- Competition
- Full and open competition
- Obligated to date
- $15,411,200
- 75A50124F61012Order under IDV 75A50122D00002THE PURPOSE OF THIS HHS TASK ORDER IS TO PROCURE SERVICES FOR THE STORAGE AND STABILITY OF BULK LOTS & FINAL CONTAINERS OF-ADJUVANT( AS03) COVID-19 FUNDS.
- Signed
- Feb 20, 2024FY2024
- Competition
- Full and open competition
- Obligated to date
- $14,047,404
- 75A50124F61015Order under IDV 75A50122D00002THIS TASK ORDER ESTABLISHES SERVICES FOR STORAGE AND STABILITY OF AS03 ADJUVANT MANUFACTURED TO SUPPORT THE COVID-19 FEDERAL RESPONSE IN BULK LOTS AND FINAL CONTAINERS FOR THE LIFE OF THE MATERIAL. ALL OPTION PERIODS ARE HEREBY EXERCISED UNDER THIS
- Signed
- Jun 17, 2024FY2024
- Competition
- Full and open competition
- Obligated to date
- $11,538,800
Recipient records grouped under this company (1)
USAspending groups recipients by its parent-company field, which has known errors. Check that the recipients below belong to GLAXOSMITHKLINE, LLC; the stock link below is made per recipient.
- GLAXOSMITHKLINE, LLC5 awards · 1 non-competed, $45.5M obligated to date
Stock ticker
Links between a federal contract recipient and an SEC-registered company, made by a written rule from SEC filings and USAspending records. Only confirmed links are shown.
No confirmed stock ticker: this may be a private company, a subsidiary awaiting review, or not matched to an SEC registrant.
Members of Congress who reported trading this stock
No confirmed stock ticker: this may be a private company, a subsidiary awaiting review, or not matched to an SEC registrant. Without a confirmed ticker, no trades are matched to this company.
Looking for agency-level shares? See non-competed share by agency.